Company intelligence / Profile preview

Motus Nova

Atlanta, Georgia, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Motus Nova's FDA Class I home-use robotic exoskeletons (Motus Hand, Motus Foot) have demonstrated clinically and statistically significant improvements in motor function, activities of daily living, and quality of life for stroke survivors, with peer-reviewed studies supporting their effectiveness in home rehabilitation. The company emphasizes increased therapy hours, cost savings, and access for patients compared to traditional outpatient rehab.

Therapeutic areas: Neurology
Modalities: DeviceRobotic exoskeleton
Industry: Assistive Medical Devices

Partnerships

Major US hospitals for clinical R&D (not individually named in public results)

Beyond the preview

Go deeper on Motus Nova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Motus Nova.

Explore the full profile